Last SFr.287.10 CHF
Change Today +1.30 / 0.45%
Volume 923.3K
ROG On Other Exchanges
Symbol
Exchange
OTC US
OTC US
OTC US
Xetra
SIX Swiss Ex
Xetra
SIX Swiss Ex
Mexico
Frankfurt
As of 11:43 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John C. Reed M.D., Ph.D.

Head of Pharma Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 8 different industries.

See Board Relationships
56--

Background*

Dr. John C. Reed, M.D, Ph.D has been the Head of Pharma Research & Early Development at Roche Holding AG since April 2, 2013. Dr. Reed serves as an Assistant Professor, Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine. He is an Adjunct professor at the University of California San Diego (UCSD) Department of Molecular Pathology, University of Florida, University of Central Florida, and in San Diego State University's ...

Read Full Background

Corporate Headquarters*

Grenzacherstrasse 124
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Co-founder and Member of Scientific Advisory Board
Member of Advisory Board
Former Director
2002-2013
Former Director
2004-N/A
Director, Member of Audit Committee, Member of Compensation Committee, and Member of Nominating Committee
2005-Present
Independent Director
2008-2009
Former Director, Member of Compensation & Option Committee and Member of Nominating & Corporate Governance Committee

Education*

BA 1980
University of Virginia
PhD 1986
The University of Pennsylvania
MD
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.287.10 CHF +1.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$8.5M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.